Stanford Ibogaine Study
Study Overview
Population: 30 male Special Operations Veterans with predominantly mild TBI and high rates of PTSD, depression, and anxiety.
Setting: Treatment occurred at Ambio Life Sciences in Mexico, where ibogaine is legal; assessments were conducted by Stanford.
Intervention: A single administration of oral ibogaine (avg. 12.1 mg/kg) combined with magnesium (to reduce cardiac risk), alongside structured coaching.
Study Name: MISTIC – Magnesium-Ibogaine: Stanford Traumatic Injury to the CNS Protocol.
Key Outcomes
What a great opportunity!